Forte Healthcare Limited has launched Cryptisel (halofuginone) 0.5mg/ml oral solution for the prevention and reduction of diarrhoea caused by Cryptosporidium parvum in calves. 

Cryptisel is for use in reducing oocyst shedding in calves where diarrhoea caused by Cryptosporidium is a problem. After the presence of the causal organism has been established, Forte says Cryptisel can be used in all new-born calves to break the cycle of transmission and multiplication on-farm.

Dr John Henderson, Large Animal Product Manager with Forte Healthcare Ltd said: "Cryptisel will be a very useful medicine in the control of the most commonly-identified scour pathogen in the UK and Ireland. Used alongside the calf-rearing cornerstones of good colostrum management, hygiene, and biosecurity, Cryptisel will reduce production of Cryptosporidium oocysts and help limit spread of the disease among susceptible calves."

Cryptisel is a POM, available in 490ml and 980ml bottles. Both sizes come with a metered dosing pump for convenient administration.

For further information, contact your local Forte Territory Manager or email enquiries@fortehealthcare.com.


Whilst you're here, take a moment to see our latest job opportunities for vets.